scispace - formally typeset
A

Anna Laura Putignano

Researcher at University of Florence

Publications -  20
Citations -  1097

Anna Laura Putignano is an academic researcher from University of Florence. The author has contributed to research in topics: Single-nucleotide polymorphism & Breast cancer. The author has an hindex of 13, co-authored 19 publications receiving 932 citations.

Papers
More filters
Journal ArticleDOI

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat, +132 more
TL;DR: Pathologic characteristics of BRCA1 and BRCa2 tumors may be useful for improving risk-prediction algorithms and informing clinical strategies for screening and prophylaxis.
Journal ArticleDOI

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.

TL;DR: The results suggest that in 3R/3R patients, the G > C polymorphism may be an important factor in determining TS mRNA expression levels, and warrant further investigation of the role of TS promoter polymorphisms as predictors of sensitivity to 5-FU-based chemotherapy in larger case series.
Journal ArticleDOI

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Antonis C. Antoniou, +183 more
TL;DR: The identification of SNPs at 6q25.1 associated with breast cancer risk for BRCA1 mutation carriers will lead to a better understanding of the biology of tumour development in these women.
Journal ArticleDOI

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

Paolo Peterlongo, +106 more
TL;DR: Evidence is provided for the first time showing that the common p.Arg1931* loss-of-function variant in FANCM is a risk factor for familial breast cancer.
Journal ArticleDOI

A PALB2 germline mutation associated with hereditary breast cancer in Italy.

TL;DR: This study supports the recent observation that PALB2 mutation are present, although infrequently, in familial BRCA1/BRCA2-negative breast cancer cases and sustains latest evidences that some PALB 2 mutations are associated with a substantially increased risk of breast cancer.